 | • レポートコード：MRC2-11QY04631 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は皮膚ガンのグローバル市場について調査・分析したレポートです。種類別（細胞癌、扁平上皮癌、黒色腫）市場規模、用途別（病院・診療所、診断センター、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別皮膚ガンの競争状況、市場シェア ・世界の皮膚ガン市場：種類別市場規模 2015年-2020年（細胞癌、扁平上皮癌、黒色腫） ・世界の皮膚ガン市場：種類別市場規模予測 2021年-2026年（細胞癌、扁平上皮癌、黒色腫） ・世界の皮膚ガン市場：用途別市場規模 2015年-2020年（病院・診療所、診断センター、がん研究所） ・世界の皮膚ガン市場：用途別市場規模予測 2021年-2026年（病院・診療所、診断センター、がん研究所） ・北米の皮膚ガン市場分析：米国、カナダ ・ヨーロッパの皮膚ガン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの皮膚ガン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の皮膚ガン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの皮膚ガン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Novartis、Sun Pharma、Elekta、Varian Medical Systems、Cannabis Science、Cellceutix、LEO Pharma、Moberg Pharma、Mylan、Eli Lilly、Bristol Myers Squibb、Boehringer Ingelheim、Aqua Pharmaceuticals、Bausch Health、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Skin cancer is the most common type of cancer, which arise due to uncontrolled growth of abnormal skin cells. It occurs when skin cells are damaged by unrepaired DNA or genetic defects that lead the uncontrolled growth of cells in the skin.
Market Analysis and Insights: Global Skin Cancer Market
The global Skin Cancer market size is projected to reach US$ 517.9 million by 2026, from US$ 491.1 million in 2020, at a CAGR of 5.0%% during 2021-2026.
Global Skin Cancer Scope and Market Size
Skin Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Skin Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Novartis
Sun Pharma
Elekta
Varian Medical Systems
Cannabis Science
Cellceutix
LEO Pharma
Moberg Pharma
Mylan
Eli Lilly
Bristol Myers Squibb
Boehringer Ingelheim
Aqua Pharmaceuticals
Bausch Health
Merck
Market segment by Type, the product can be split into
Cell carcinoma
Squamous-cell carcinoma
Melanoma
Market segment by Application, split into
Hospital and clinics
Diagnostic centers
Cancer research institute
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Skin Cancer Revenue
1.4 Market by Type
1.4.1 Global Skin Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell carcinoma
1.4.3 Squamous-cell carcinoma
1.4.4 Melanoma
1.5 Market by Application
1.5.1 Global Skin Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospital and clinics
1.5.3 Diagnostic centers
1.5.4 Cancer research institute
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Skin Cancer Market Perspective (2015-2026)
2.2 Global Skin Cancer Growth Trends by Regions
2.2.1 Skin Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Skin Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Skin Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Skin Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Skin Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Skin Cancer Players by Market Size
3.1.1 Global Top Skin Cancer Players by Revenue (2015-2020)
3.1.2 Global Skin Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Skin Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Skin Cancer Market Concentration Ratio
3.2.1 Global Skin Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Skin Cancer Revenue in 2019
3.3 Skin Cancer Key Players Head office and Area Served
3.4 Key Players Skin Cancer Product Solution and Service
3.5 Date of Enter into Skin Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Skin Cancer Historic Market Size by Type (2015-2020)
4.2 Global Skin Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Skin Cancer Market Size by Application (2015-2020)
5.2 Global Skin Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Skin Cancer Market Size (2015-2020)
6.2 Skin Cancer Key Players in North America (2019-2020)
6.3 North America Skin Cancer Market Size by Type (2015-2020)
6.4 North America Skin Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Skin Cancer Market Size (2015-2020)
7.2 Skin Cancer Key Players in Europe (2019-2020)
7.3 Europe Skin Cancer Market Size by Type (2015-2020)
7.4 Europe Skin Cancer Market Size by Application (2015-2020)
8 China
8.1 China Skin Cancer Market Size (2015-2020)
8.2 Skin Cancer Key Players in China (2019-2020)
8.3 China Skin Cancer Market Size by Type (2015-2020)
8.4 China Skin Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Skin Cancer Market Size (2015-2020)
9.2 Skin Cancer Key Players in Japan (2019-2020)
9.3 Japan Skin Cancer Market Size by Type (2015-2020)
9.4 Japan Skin Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Skin Cancer Market Size (2015-2020)
10.2 Skin Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Skin Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Skin Cancer Market Size by Application (2015-2020)
11 India
11.1 India Skin Cancer Market Size (2015-2020)
11.2 Skin Cancer Key Players in India (2019-2020)
11.3 India Skin Cancer Market Size by Type (2015-2020)
11.4 India Skin Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Skin Cancer Market Size (2015-2020)
12.2 Skin Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Skin Cancer Market Size by Type (2015-2020)
12.4 Central & South America Skin Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Skin Cancer Introduction
13.1.4 Roche Revenue in Skin Cancer Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Skin Cancer Introduction
13.2.4 Novartis Revenue in Skin Cancer Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Sun Pharma
13.3.1 Sun Pharma Company Details
13.3.2 Sun Pharma Business Overview
13.3.3 Sun Pharma Skin Cancer Introduction
13.3.4 Sun Pharma Revenue in Skin Cancer Business (2015-2020)
13.3.5 Sun Pharma Recent Development
13.4 Elekta
13.4.1 Elekta Company Details
13.4.2 Elekta Business Overview
13.4.3 Elekta Skin Cancer Introduction
13.4.4 Elekta Revenue in Skin Cancer Business (2015-2020)
13.4.5 Elekta Recent Development
13.5 Varian Medical Systems
13.5.1 Varian Medical Systems Company Details
13.5.2 Varian Medical Systems Business Overview
13.5.3 Varian Medical Systems Skin Cancer Introduction
13.5.4 Varian Medical Systems Revenue in Skin Cancer Business (2015-2020)
13.5.5 Varian Medical Systems Recent Development
13.6 Cannabis Science
13.6.1 Cannabis Science Company Details
13.6.2 Cannabis Science Business Overview
13.6.3 Cannabis Science Skin Cancer Introduction
13.6.4 Cannabis Science Revenue in Skin Cancer Business (2015-2020)
13.6.5 Cannabis Science Recent Development
13.7 Cellceutix
13.7.1 Cellceutix Company Details
13.7.2 Cellceutix Business Overview
13.7.3 Cellceutix Skin Cancer Introduction
13.7.4 Cellceutix Revenue in Skin Cancer Business (2015-2020)
13.7.5 Cellceutix Recent Development
13.8 LEO Pharma
13.8.1 LEO Pharma Company Details
13.8.2 LEO Pharma Business Overview
13.8.3 LEO Pharma Skin Cancer Introduction
13.8.4 LEO Pharma Revenue in Skin Cancer Business (2015-2020)
13.8.5 LEO Pharma Recent Development
13.9 Moberg Pharma
13.9.1 Moberg Pharma Company Details
13.9.2 Moberg Pharma Business Overview
13.9.3 Moberg Pharma Skin Cancer Introduction
13.9.4 Moberg Pharma Revenue in Skin Cancer Business (2015-2020)
13.9.5 Moberg Pharma Recent Development
13.10 Mylan
13.10.1 Mylan Company Details
13.10.2 Mylan Business Overview
13.10.3 Mylan Skin Cancer Introduction
13.10.4 Mylan Revenue in Skin Cancer Business (2015-2020)
13.10.5 Mylan Recent Development
13.11 Eli Lilly
10.11.1 Eli Lilly Company Details
10.11.2 Eli Lilly Business Overview
10.11.3 Eli Lilly Skin Cancer Introduction
10.11.4 Eli Lilly Revenue in Skin Cancer Business (2015-2020)
10.11.5 Eli Lilly Recent Development
13.12 Bristol Myers Squibb
10.12.1 Bristol Myers Squibb Company Details
10.12.2 Bristol Myers Squibb Business Overview
10.12.3 Bristol Myers Squibb Skin Cancer Introduction
10.12.4 Bristol Myers Squibb Revenue in Skin Cancer Business (2015-2020)
10.12.5 Bristol Myers Squibb Recent Development
13.13 Boehringer Ingelheim
10.13.1 Boehringer Ingelheim Company Details
10.13.2 Boehringer Ingelheim Business Overview
10.13.3 Boehringer Ingelheim Skin Cancer Introduction
10.13.4 Boehringer Ingelheim Revenue in Skin Cancer Business (2015-2020)
10.13.5 Boehringer Ingelheim Recent Development
13.14 Aqua Pharmaceuticals
10.14.1 Aqua Pharmaceuticals Company Details
10.14.2 Aqua Pharmaceuticals Business Overview
10.14.3 Aqua Pharmaceuticals Skin Cancer Introduction
10.14.4 Aqua Pharmaceuticals Revenue in Skin Cancer Business (2015-2020)
10.14.5 Aqua Pharmaceuticals Recent Development
13.15 Bausch Health
10.15.1 Bausch Health Company Details
10.15.2 Bausch Health Business Overview
10.15.3 Bausch Health Skin Cancer Introduction
10.15.4 Bausch Health Revenue in Skin Cancer Business (2015-2020)
10.15.5 Bausch Health Recent Development
13.16 Merck
10.16.1 Merck Company Details
10.16.2 Merck Business Overview
10.16.3 Merck Skin Cancer Introduction
10.16.4 Merck Revenue in Skin Cancer Business (2015-2020)
10.16.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Skin Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Skin Cancer Revenue
Table 3. Ranking of Global Top Skin Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Skin Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cell carcinoma
Table 6. Key Players of Squamous-cell carcinoma
Table 7. Key Players of Melanoma
Table 8. Global Skin Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Skin Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Skin Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Skin Cancer Market Share by Regions (2015-2020)
Table 12. Global Skin Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Skin Cancer Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Skin Cancer Market Growth Strategy
Table 18. Main Points Interviewed from Key Skin Cancer Players
Table 19. Global Skin Cancer Revenue by Players (2015-2020) (Million US$)
Table 20. Global Skin Cancer Market Share by Players (2015-2020)
Table 21. Global Top Skin Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer as of 2019)
Table 22. Global Skin Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Skin Cancer Product Solution and Service
Table 25. Date of Enter into Skin Cancer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Skin Cancer Market Size by Type (2015-2020) (Million US$)
Table 28. Global Skin Cancer Market Size Share by Type (2015-2020)
Table 29. Global Skin Cancer Revenue Market Share by Type (2021-2026)
Table 30. Global Skin Cancer Market Size Share by Application (2015-2020)
Table 31. Global Skin Cancer Market Size by Application (2015-2020) (Million US$)
Table 32. Global Skin Cancer Market Size Share by Application (2021-2026)
Table 33. North America Key Players Skin Cancer Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Skin Cancer Market Share (2019-2020)
Table 35. North America Skin Cancer Market Size by Type (2015-2020) (Million US$)
Table 36. North America Skin Cancer Market Share by Type (2015-2020)
Table 37. North America Skin Cancer Market Size by Application (2015-2020) (Million US$)
Table 38. North America Skin Cancer Market Share by Application (2015-2020)
Table 39. Europe Key Players Skin Cancer Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Skin Cancer Market Share (2019-2020)
Table 41. Europe Skin Cancer Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Skin Cancer Market Share by Type (2015-2020)
Table 43. Europe Skin Cancer Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Skin Cancer Market Share by Application (2015-2020)
Table 45. China Key Players Skin Cancer Revenue (2019-2020) (Million US$)
Table 46. China Key Players Skin Cancer Market Share (2019-2020)
Table 47. China Skin Cancer Market Size by Type (2015-2020) (Million US$)
Table 48. China Skin Cancer Market Share by Type (2015-2020)
Table 49. China Skin Cancer Market Size by Application (2015-2020) (Million US$)
Table 50. China Skin Cancer Market Share by Application (2015-2020)
Table 51. Japan Key Players Skin Cancer Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Skin Cancer Market Share (2019-2020)
Table 53. Japan Skin Cancer Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Skin Cancer Market Share by Type (2015-2020)
Table 55. Japan Skin Cancer Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Skin Cancer Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Skin Cancer Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Skin Cancer Market Share (2019-2020)
Table 59. Southeast Asia Skin Cancer Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Skin Cancer Market Share by Type (2015-2020)
Table 61. Southeast Asia Skin Cancer Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Skin Cancer Market Share by Application (2015-2020)
Table 63. India Key Players Skin Cancer Revenue (2019-2020) (Million US$)
Table 64. India Key Players Skin Cancer Market Share (2019-2020)
Table 65. India Skin Cancer Market Size by Type (2015-2020) (Million US$)
Table 66. India Skin Cancer Market Share by Type (2015-2020)
Table 67. India Skin Cancer Market Size by Application (2015-2020) (Million US$)
Table 68. India Skin Cancer Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Skin Cancer Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Skin Cancer Market Share (2019-2020)
Table 71. Central & South America Skin Cancer Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Skin Cancer Market Share by Type (2015-2020)
Table 73. Central & South America Skin Cancer Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Skin Cancer Market Share by Application (2015-2020)
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Product
Table 78. Roche Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 79. Roche Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Product
Table 83. Novartis Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 84. Novartis Recent Development
Table 85. Sun Pharma Company Details
Table 86. Sun Pharma Business Overview
Table 87. Sun Pharma Product
Table 88. Sun Pharma Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 89. Sun Pharma Recent Development
Table 90. Elekta Company Details
Table 91. Elekta Business Overview
Table 92. Elekta Product
Table 93. Elekta Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 94. Elekta Recent Development
Table 95. Varian Medical Systems Company Details
Table 96. Varian Medical Systems Business Overview
Table 97. Varian Medical Systems Product
Table 98. Varian Medical Systems Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 99. Varian Medical Systems Recent Development
Table 100. Cannabis Science Company Details
Table 101. Cannabis Science Business Overview
Table 102. Cannabis Science Product
Table 103. Cannabis Science Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 104. Cannabis Science Recent Development
Table 105. Cellceutix Company Details
Table 106. Cellceutix Business Overview
Table 107. Cellceutix Product
Table 108. Cellceutix Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 109. Cellceutix Recent Development
Table 110. LEO Pharma Business Overview
Table 111. LEO Pharma Product
Table 112. LEO Pharma Company Details
Table 113. LEO Pharma Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 114. LEO Pharma Recent Development
Table 115. Moberg Pharma Company Details
Table 116. Moberg Pharma Business Overview
Table 117. Moberg Pharma Product
Table 118. Moberg Pharma Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 119. Moberg Pharma Recent Development
Table 120. Mylan Company Details
Table 121. Mylan Business Overview
Table 122. Mylan Product
Table 123. Mylan Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 124. Mylan Recent Development
Table 125. Eli Lilly Company Details
Table 126. Eli Lilly Business Overview
Table 127. Eli Lilly Product
Table 128. Eli Lilly Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 129. Eli Lilly Recent Development
Table 130. Bristol Myers Squibb Company Details
Table 131. Bristol Myers Squibb Business Overview
Table 132. Bristol Myers Squibb Product
Table 133. Bristol Myers Squibb Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 134. Bristol Myers Squibb Recent Development
Table 135. Boehringer Ingelheim Company Details
Table 136. Boehringer Ingelheim Business Overview
Table 137. Boehringer Ingelheim Product
Table 138. Boehringer Ingelheim Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 139. Boehringer Ingelheim Recent Development
Table 140. Aqua Pharmaceuticals Company Details
Table 141. Aqua Pharmaceuticals Business Overview
Table 142. Aqua Pharmaceuticals Product
Table 143. Aqua Pharmaceuticals Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 144. Aqua Pharmaceuticals Recent Development
Table 145. Bausch Health Company Details
Table 146. Bausch Health Business Overview
Table 147. Bausch Health Product
Table 148. Bausch Health Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 149. Bausch Health Recent Development
Table 150. Merck Company Details
Table 151. Merck Business Overview
Table 152. Merck Product
Table 153. Merck Revenue in Skin Cancer Business (2015-2020) (Million US$)
Table 154. Merck Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Skin Cancer Market Share by Type: 2020 VS 2026
Figure 2. Cell carcinoma Features
Figure 3. Squamous-cell carcinoma Features
Figure 4. Melanoma Features
Figure 5. Global Skin Cancer Market Share by Application: 2020 VS 2026
Figure 6. Hospital and clinics Case Studies
Figure 7. Diagnostic centers Case Studies
Figure 8. Cancer research institute Case Studies
Figure 9. Skin Cancer Report Years Considered
Figure 10. Global Skin Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Skin Cancer Market Share by Regions: 2020 VS 2026
Figure 12. Global Skin Cancer Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Skin Cancer Market Share by Players in 2019
Figure 15. Global Top Skin Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Skin Cancer Revenue in 2019
Figure 17. North America Skin Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Skin Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Skin Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Skin Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Skin Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Skin Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Skin Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
皮膚がん診断・治療の世界市場（～2026年） Skin cancer is the uncontrolled development of anomalous skin cells. The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. Market Analysis and Insights: Global Skin Cancer Diagnosis and Therapeutics Market Th…- 非黒色腫皮膚がんの世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 非黒色腫皮膚がん治療の世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 皮膚がん治療薬の世界市場（～2026年） On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the exte…
- 頭頸部扁平上皮がん (HNSCC)治療の世界市場（～2026年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…